A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.
about
Interim results of an ecological experiment - Conjugate vaccination against the pneumococcus and serotype replacementBiological and Epidemiological Features of Antibiotic-Resistant Streptococcus pneumoniae in Pre- and Post-Conjugate Vaccine Eras: a United States Perspective.A model-based analysis: what potential could there be for a S. aureus vaccine in a hospital setting on top of other preventative measures?Efficacy of 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine against acute otitis media and nasopharyngeal carriage in Panamanian children - A randomized controlled trialLinking data and models: the importance of statistical analyses to inform models for the transmission dynamics of infections.Pneumococcal transmission and disease in silico: a microsimulation model of the indirect effects of vaccination.Natural antibodies against several pneumococcal virulence proteins in children during the pre-pneumococcal-vaccine era: the generation R study.Shifting genetic structure of invasive serotype 19A pneumococci in the United StatesModelling effectiveness of herd level vaccination against Q fever in dairy cattle.Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization.Vaccination Drives Changes in Metabolic and Virulence Profiles of Streptococcus pneumoniae.Pneumococcal serotypes in children in 4 European countriesTowards New Broader Spectrum Pneumococcal Vaccines: The Future of Pneumococcal Disease Prevention.Impact of pneumococcal conjugate vaccination on otitis media: a systematic reviewPediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.A modeling framework for the evolution and spread of antibiotic resistance: literature review and model categorization.Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United StatesExploring the population-level impact of MenB vaccination via modeling: Potential for serogroup replacement.A basic dynamic transmission model of Staphylococcus aureus in the US population.Review on the immunogenicity and safety of PCV-13 in infants and toddlers.Predicting the impact of new pneumococcal conjugate vaccines: serotype composition is not enough.Invasive pneumococcal infection despite 7-valent conjugated vaccine.Harnessing Intra-Host Strain Competition to Limit Antibiotic Resistance: Mathematical Model Results.Exploring the role of competition induced by non-vaccine serotypes for herd protection following pneumococcal vaccination.Outpatient antibiotic prescribing and nonsusceptible Streptococcus pneumoniae in the United States, 1996-2003.Potential impact of introducing the pneumococcal conjugate vaccine into national immunisation programmes: an economic-epidemiological analysis using data from India.
P2860
Q28069508-5CAF34A0-B394-4005-A719-0DD14A2CF0DDQ30251593-D0015E11-E2E8-4824-BF5B-895EFFEB1C19Q33714965-6C8DEE86-6F2C-46ED-AA77-79680E87CA38Q33848675-A710903D-FB28-4079-9E0E-39136AE1D097Q34290122-F9FAE83A-2AD6-49EA-AA3C-C22B7841D54FQ34606511-4AD3318D-3D58-41F1-AAF7-F0B098F388BDQ34740228-A4942BFD-EE55-411B-8652-FFF40A25E664Q34834011-22AB82E8-BE2F-4E70-A90F-94E5D2F15491Q35074002-9D8875F3-474B-4156-A08E-471961D85E01Q35199219-225DB77B-175A-4811-86AE-DABB14D0C306Q35693577-FEA89CAD-630C-472E-9D3A-4CA26BC1CD4DQ35806522-109F034B-566F-4B7F-911F-D6F00BC1866AQ35826592-7CFB1570-AEF4-48C9-A780-F6B8D2A804EBQ35977422-A226C195-9768-4E4E-BD53-A261733C987DQ36156085-B58C972B-77A3-4FBE-8531-29A7A84F7146Q37078552-02341CDA-0A5E-4100-B2F9-32CD7CDD4E1DQ37187505-3D63CC9E-7F4B-4F44-8F2F-01950E043844Q37309237-86264850-4E9B-4155-9D04-CFA2898A9929Q37561178-17AA7CDB-0D7C-45BA-8E7D-CA04F9AD7596Q37909417-E02D671A-1C04-4607-BA10-9BFFD4330373Q38255287-C087375F-EE22-4933-9931-34E63A58E9D5Q38678793-8F9384AE-A49D-4738-828B-C0C801766989Q40527039-425AA23B-E8BC-48B9-8A9E-CCD9F576FF4EQ47115918-5AFA22A7-98BB-4705-A4E1-848B03EC2CC1Q51169250-16EB72CF-D193-4A4C-8D3C-97107E6270D2Q55126608-3FC5FBBA-15AF-43FA-A9DF-5820BBC5CFB7
P2860
A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
A dynamic model of pneumococca ...... revention through vaccination.
@en
A dynamic model of pneumococca ...... revention through vaccination.
@nl
type
label
A dynamic model of pneumococca ...... revention through vaccination.
@en
A dynamic model of pneumococca ...... revention through vaccination.
@nl
prefLabel
A dynamic model of pneumococca ...... revention through vaccination.
@en
A dynamic model of pneumococca ...... revention through vaccination.
@nl
P2093
P1433
P1476
A dynamic model of pneumococca ...... prevention through vaccination
@en
P2093
Cynthia G Whitney
Frederik Fierens
Matthew R Moore
Thierry Van Effelterre
William P Hausdorff
P304
P356
10.1016/J.VACCINE.2010.03.030
P407
P577
2010-03-30T00:00:00Z